Influential factors and therapeutic options for erectile dysfunction in allograft renal transplantation recipients.
- Author:
Zheng-guo JI
1
;
Ye TIAN
;
Li-sheng CHEN
Author Information
1. Depatment of Urology, Beijing Friendship Hospital, Capital Uniersity of Medical Science, Beijing 100500, China. zhengguo_ji@hotmail.com
- Publication Type:Journal Article
- MeSH:
Erectile Dysfunction;
epidemiology;
therapy;
Humans;
Kidney Transplantation;
adverse effects;
Male;
Prevalence;
Quality of Life;
Transplantation, Homologous;
adverse effects
- From:
National Journal of Andrology
2007;13(4):360-363
- CountryChina
- Language:Chinese
-
Abstract:
The quality of sexual life is important for renal transplantation recipients. With the increase of survival rate of renal transplantation, the quality of the male recipients' sexual life, especially their erectile function, has been generally remarked. The prevalence of ED is 35.8%-78.3% in male allograft renal transplantation recipients. And it can be caused by various factors, such as age, dialysis time, modus operandi, hemoglobin level, deprementia, immunosuppressant, and diabetes. We give an overview of the therapeutic options for ED in this special population. Sildenafil is effective and safe. If the oral drug fails, we can choose intracavernosal injection and penile prosthesis implantation. Nevertheless, three-piece prostheses should be avoided.
